Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,254,042
  • Shares Outstanding, K 352,142
  • Annual Sales, $ 8,601 M
  • Annual Income, $ -1,788,000 K
  • 60-Month Beta 1.27
  • Price/Sales 0.74
  • Price/Cash Flow 1.73
  • Price/Book 8.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.67
  • Number of Estimates 6
  • High Estimate 0.83
  • Low Estimate 0.53
  • Prior Year 1.03
  • Growth Rate Est. (year over year) -34.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.50 +14.58%
on 05/14/20
18.99 -6.48%
on 04/29/20
+1.40 (+8.56%)
since 04/22/20
3-Month
11.15 +59.28%
on 03/18/20
26.37 -32.65%
on 02/25/20
-8.74 (-32.98%)
since 02/21/20
52-Week
11.15 +59.28%
on 03/18/20
31.97 -44.45%
on 12/13/19
-6.68 (-27.33%)
since 05/22/19

Most Recent Stories

More News
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offering of ,000 aggregate principal...

BHC : 17.76 (-2.31%)
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of ,000 aggregate principal amount of new senior notes...

BHC : 17.76 (-2.31%)
Bausch (BHC) Down on Q1 Earnings & Sales Miss, View Trimmed

Bausch (BHC) misses on earnings and sales in the first quarter and lowers guidance due to the coronavirus pandemic.

ENDP : 3.86 (-1.28%)
NVS : 84.91 (-0.09%)
MNK : 3.37 (-0.30%)
BHC : 17.76 (-2.31%)
Endo (ENDP) Q1 Earnings Beat on Coronavirus-Led Stockpiling

Endo's (ENDP) earnings and sales beat estimates in the first quarter owing to increased customer inventory purchasing due to the COVID-19 pandemic

ENDP : 3.86 (-1.28%)
INFI : 0.9699 (+3.92%)
MNK : 3.37 (-0.30%)
BHC : 17.76 (-2.31%)
Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

Bausch (BHC) delivered earnings and revenue surprises of -1.11% and -1.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

BHC : 17.76 (-2.31%)
Bausch Health Companies Inc. Announces First-Quarter 2020 Results

, /PRNewswire/ --

BHC : 17.76 (-2.31%)
Should You Buy Bausch Health (BHC) Ahead of Earnings?

Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHC : 17.76 (-2.31%)
Bausch Health (BHC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Bausch (BHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BHC : 17.76 (-2.31%)
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that  Joseph C. Papa, chairman and chief executive officer, and , senior vice president and head of Investor Relations...

BHC : 17.76 (-2.31%)
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed...

BHC : 17.76 (-2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BHC with:

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

2nd Resistance Point 18.37
1st Resistance Point 18.06
Last Price 17.76
1st Support Level 17.50
2nd Support Level 17.25

See More

52-Week High 31.97
Fibonacci 61.8% 24.02
Fibonacci 50% 21.56
Fibonacci 38.2% 19.10
Last Price 17.76
52-Week Low 11.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar